Johns A - Search Results

1

FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834.

McLean K, Schirm S, Johns A, Morser J, Light DR. McLean K, et al. Among authors: johns a. Thromb Res. 2001 Aug 15;103(4):281-97. doi: 10.1016/s0049-3848(01)00330-9. Thromb Res. 2001. PMID: 11562339

2

Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.

Wang YX, Martin-McNulty B, da Cunha V, Vincelette J, Lu X, Feng Q, Halks-Miller M, Mahmoudi M, Schroeder M, Subramanyam B, Tseng JL, Deng GD, Schirm S, Johns A, Kauser K, Dole WP, Light DR. Wang YX, et al. Among authors: johns a. Circulation. 2005 May 3;111(17):2219-26. doi: 10.1161/01.CIR.0000163544.17221.BE. Epub 2005 Apr 25. Circulation. 2005. PMID: 15851596

3

Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.

Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG. Gu JM, et al. Among authors: johns a. J Cell Physiol. 2005 Jul;204(1):73-82. doi: 10.1002/jcp.20262. J Cell Physiol. 2005. PMID: 15573379

4

Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.

Wang YX, da Cunha V, Martin-McNulty B, Vincelette J, Li W, Choy DF, Halks-Miller M, Mahmoudi M, Schroeder M, Johns A, Light DR, Dole WP. Wang YX, et al. Among authors: johns a. Eur J Pharmacol. 2005 Apr 11;512(2-3):215-22. doi: 10.1016/j.ejphar.2005.02.024. Eur J Pharmacol. 2005. PMID: 15840407

5

A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase.

Seto M, Whitlow M, McCarrick MA, Srinivasan S, Zhu Y, Pagila R, Mintzer R, Light D, Johns A, Meurer-Ogden JA. Seto M, et al. Among authors: johns a. Protein Sci. 2004 Dec;13(12):3172-86. doi: 10.1110/ps.04966204. Protein Sci. 2004. PMID: 15557261 Free PMC article.

6

Role of estrogen receptors in the vascular system.

Rubanyi GM, Kauser K, Johns A. Rubanyi GM, et al. Among authors: johns a. Vascul Pharmacol. 2002 Feb;38(2):81-8. doi: 10.1016/s0306-3623(02)00130-1. Vascul Pharmacol. 2002. PMID: 12379954 Review.

7

Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells.

Mintzer RJ, Croze E, Rubanyi GM, Johns A. Mintzer RJ, et al. Among authors: johns a. J Interferon Cytokine Res. 1998 Nov;18(11):939-45. doi: 10.1089/jir.1998.18.939. J Interferon Cytokine Res. 1998. PMID: 9858315

8

Effect of estrogen on endothelial function and angiogenesis.

Rubanyi GM, Johns A, Kauser K. Rubanyi GM, et al. Among authors: johns a. Vascul Pharmacol. 2002 Feb;38(2):89-98. doi: 10.1016/s0306-3623(02)00131-3. Vascul Pharmacol. 2002. PMID: 12379955 Review.

9

Phorbol dibutyrate stimulates the release of diffusible endothelium-derived vasoconstrictor factor(s) from canine femoral arteries.

Rubanyi GM, Luisi A, Johns A. Rubanyi GM, et al. Among authors: johns a. Circ Res. 1991 Jun;68(6):1527-31. doi: 10.1161/01.res.68.6.1527. Circ Res. 1991. PMID: 2036708

10

Endothelium derived relaxing factor release from canine coronary artery by leukocytes.

Kleha JF, Devesly P, Johns A. Kleha JF, et al. Among authors: johns a. Can J Physiol Pharmacol. 1995 Mar;73(3):404-8. doi: 10.1139/y95-052. Can J Physiol Pharmacol. 1995. PMID: 7648520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

465 results

Search Page